Tvardi Therapeutics, Inc.
Statements
Cash Flow
Tvardi Therapeutics, Inc. (TVRD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -5.5 | -60 | -18 | -92 | -61 | -23 | |
| 1.0 | 1.6 | 0.1 | 0.3 | 0.2 | 0.1 | |
| – | – | 0.2 | 0.3 | 0.3 | 1.4 | |
| -7.4 | 5.3 | 2.7 | 10 | -15 | 0.5 | |
| 0.3 | 0.0 | 0.1 | 2.4 | 1.0 | 0.0 | |
| -20 | -4.8 | -22 | 43 | 49 | -10 | |
| – | – | – | – | 28 | 0.0 | |
| 39 | 47 | 0.0 | 38 | -3.6 | 23 | |
| 13 | -18 | -40 | -12 | -14 | -11 | |
| -5.8 | -60 | -18 | -94 | -62 | -23 |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.